HALO logo
halo search icon
MRK
Merck & Co., Inc.

MRK · Merck & Co., Inc.

145.95

USD
0.76 (0.523%)
16/10/2026 04:10:00 PM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$360.08B

PE

N/A

EV/EBITDA

N/A

DIV Yield

N/A

Payout Ratio

N/A

MQV Rating

4Weak

As at 16/10/2026 04:10:00 PM

Price Chart

Description

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Capital Efficiency
  • Hammer Bearish
  • Hammer Bearish (Realtime)
  • Recent Price upgrade

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

N/A

Trade Value (12mth)

N/A

1 week

%

1 month

%

YTD

%

1 year

%

All time high

N/A

Additional Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

N/A

Short Sell (% of issue)

lock

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
14 October 26EDG
14 October 26EDG
08 August 26EDG
04 August 26EDG
04 August 26EDG

Key Stakeholders

NameTitle
OrbiMed Advisors Private EquitySubsidiary
Employees Provident Fund (Investment Management)Operating Division
Robert M. DavisIndividual
Sanat ChattopadhyayIndividual
Richard R. DeLucaIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current share price of Merck & Co., Inc. (MRK:NYS) is USD$145.95.
2
What is the 52-week high share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week high share price for Merck & Co., Inc. (MRK:NYS) is USD$0.00.
3
What is the 52-week low share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week low share price for Merck & Co., Inc. (MRK:NYS) is USD$0.00.
4
What is the dividend yield for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) does not pay a dividend.
5
What was Merck & Co., Inc. (MRK:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Merck & Co., Inc. (MRK:NYS) is USD$0.85.
6
What is the franking level for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) has a franking level of 0.00%.
7
In which sector is Merck & Co., Inc. (MRK:NYS) classified?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) is classified in the Healthcare.